Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENSIGN GROUP, INCENSG · Entity 3521 | Director | July 20, 2026 | July 22, 2026 |
| HERBALIFE LTD.HLF · Entity 4842 | Director · Chairman and CEO | May 10, 2022 | May 11, 2022 |
| MAGELLAN HEALTH INCMGLN · Entity 131790 | Director | May 24, 2018 | May 25, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENSIGN GROUP, INC
Report date July 20, 2026 · Filed July 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,503.149 |
Reported balance
After 2026-07-20 transaction · row 1
1 source rowRow 1 · 2026-07-20 · Sale · Disposed 392 · Balance 9,503.149 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on July 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on July 31, 2025.
HERBALIFE LTD.
Report date May 10, 2022 · Filed May 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,745 |
Reported balance
After 2022-05-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-10 · Purchase · Acquired 4,222 · Balance 134,745 F1: This transaction was executed in multiple trades at prices ranging from $23.38 to $23.72. The price reported reflects the weighted average purchase price of $23.5514. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $23.38 to $23.72. The price reported reflects the weighted average purchase price of $23.5514. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4.
MAGELLAN HEALTH INC
Report date May 24, 2018 · Filed May 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 9,267 |
Reported balance
After 2018-05-24 transaction · row 1
1 source rowRow 1 · 2018-05-24 · Grant · Acquired 1,685 · Balance 9,267 F1: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders. F2: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders.
F2: Not applicable.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
bluebird bio, Inc.
Report date May 30, 2025 · Filed June 03, 2025
Section 16 reporting ended · disclosed 2025-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-06-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-05-30 · Other · Disposed 1,323 · Balance 1,245 F1: In connection with the terms of an Agreement and Plan of Merger, dated as of February 21, 2025 (as amended, the "Merger Agreement"), by and among the Issuer, Beacon Parent Holdings, L.P. ("Parent") and Beacon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. Tendering stockholders were given the option to receive per share consideration of either (x) $3.00 in cash per share, subject to any applicable withholding taxes and without interest thereon, plus one contingent value right ("CVR") per share, representing the right to receive one contingent payment of $6.84, in cash, subject to any applicable withholding taxes and without interest thereon, upon achievement of the specified milestone or (y) $5.00 in cash per share, subject to any applicable withholding taxes and without interest thereon (collectively, the "Offer Price"). F2: (Continued from footnote 1) After completion of the tender offer, Purchaser merged with and into the Issuer (the "Merger"), effective as of June 2, 2025 (the "Effective Time"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent. Row 2 · 2025-06-02 · Disposition to issuer · Disposed 1,245 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each time-based restricted stock unit award with respect to shares that is, at the time of determination, subject to vesting or forfeiture conditions and that is not a PSU Award (as defined below) (but including, for clarity, any PSU Award that is subject solely to service-based vesting conditions as of the Effective Time) ("RSU Award") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive F4: (Continued from footnote 3) (i) an amount in cash equal to the product of the number of shares underlying such RSU Award immediately prior to the Effective Time and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each share subject to such RSU Award immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the terms of an Agreement and Plan of Merger, dated as of February 21, 2025 (as amended, the "Merger Agreement"), by and among the Issuer, Beacon Parent Holdings, L.P. ("Parent") and Beacon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. Tendering stockholders were given the option to receive per share consideration of either (x) $3.00 in cash per share, subject to any applicable withholding taxes and without interest thereon, plus one contingent value right ("CVR") per share, representing the right to receive one contingent payment of $6.84, in cash, subject to any applicable withholding taxes and without interest thereon, upon achievement of the specified milestone or (y) $5.00 in cash per share, subject to any applicable withholding taxes and without interest thereon (collectively, the "Offer Price").
F2: (Continued from footnote 1) After completion of the tender offer, Purchaser merged with and into the Issuer (the "Merger"), effective as of June 2, 2025 (the "Effective Time"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent.
F3: Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each time-based restricted stock unit award with respect to shares that is, at the time of determination, subject to vesting or forfeiture conditions and that is not a PSU Award (as defined below) (but including, for clarity, any PSU Award that is subject solely to service-based vesting conditions as of the Effective Time) ("RSU Award") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive
F4: (Continued from footnote 3) (i) an amount in cash equal to the product of the number of shares underlying such RSU Award immediately prior to the Effective Time and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each share subject to such RSU Award immediately prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2021 Filed Feb 24, 2021 01:34 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 838 | $48.33 | $40,500.54 |
DisclosureSEC source: 0001209191-21-013526 · doc4.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,149 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:34 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 23,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013526 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,987 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 17,110 | $55.83 | $955,251.30 |
DisclosureSEC source: 0001209191-21-009476 · doc4.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,710 F3 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 38,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009476 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,820 F1 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:27 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $64.09 | $0.00 |
DisclosureSEC source: 0001562180-20-004617 · primarydocument.xml · derivative · entry 3 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2030-06-18 F2 · derivative.exercise_date: This option vests 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:27 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004617 · primarydocument.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,324 F1 · security: These restricted stock units for common stock vest 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:27 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantCommon Stock | 124 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004617 · primarydocument.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,824 F1 · security: These restricted stock units for common stock vest 100% on the earlier of June 18, 2021 or the date of the next annual meeting of stockholders. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:09 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 19,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022093 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,273 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on March 30, 2021, 20% on March 30, 2022, and 60% on March 30, 2023, subject to continued service through each applicable date. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 513 | $33.27 | $17,067.51 |
DisclosureSEC source: 0001209191-20-013920 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Co-President/Chief H&N Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,056 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 462 | $37.45 | $17,301.90 |
DisclosureSEC source: 0001209191-20-011984 · doc4.xml · nonDerivative · entry 2 Agwunobi John O · CIK 0001627893 · Co-President/Chief H&N Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,569 F2 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 21, 2019. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 8,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011984 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Co-President/Chief H&N Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,031 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 20, 2021, 20% on February 20, 2022, and 60% on February 20, 2023, subject to continued service through each applicable date. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:17 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $122.01 | $0.00 |
DisclosureSEC source: 0001209191-19-035782 · doc4.xml · derivative · entry 2 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2029-06-06 F2 · derivative.exercise_date: This option vests 100% on the earlier of June 6, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:17 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035782 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 F1 · security: These restricted stock units for common stock vest 100% on the earlier of June 6, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:51 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 538 | $56.52 | $30,407.76 |
DisclosureSEC source: 0001209191-19-014550 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Co-President/Chief H&N Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,577 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:51 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013021 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Co-President/Chief H&N Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,115 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 21, 2020, 20% on February 21, 2021, and 60% on February 21, 2022, subject to continued service through each applicable date. F2 · balance_after: Reflects 3,707 additional shares of common stock, after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:17 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $183.10 | $0.00 |
DisclosureSEC source: 0001209191-18-039186 · doc4.xml · derivative · entry 2 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2028-06-20 F2 · derivative.exercise_date: This option vests 100% on the earlier of June 20, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:17 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039186 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 F1 · security: These restricted stock units for common stock vest 100% on the earlier of June 20, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| May 24, 2018 Filed May 25, 2018 17:13 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 1,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033577 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,267 F1 · shares: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders. F2 · price: Not applicable. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:53 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantStock Option (right to buy) · Derivative | 10,700 | $0.00 Strike: $111.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039196 · doc4.xml · derivative · entry 2 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 10,700 shares Expires 2027-06-08 F2 · derivative.exercise_date: This option vests ratably over three years in annual installments, commencing on June 8, 2017. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:53 UTC | bluebird bio, Inc. BLUE · Entity 78923 | GrantCommon Stock | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039196 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 F1 · security: These restricted stock units for common stock vest ratable over three years in annual installments, commencing on June 8, 2017. Read SEC document |
| May 24, 2017 Filed May 26, 2017 12:59 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 2,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035736 · doc4.xml · nonDerivative · entry 1 Agwunobi John O · CIK 0001627893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,582 F1 · shares: Shares shall vest fully on the date of the 2018 Annual Meeting of Shareholders. F2 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.